This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Capecitabine 150 mg tablets. The contract, valued at $1,094.60, has a period of performance through May 18, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to deliver a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,982,789 units of the medication Capecitabine 500 mg tablets. The contract has a ceiling value of $1,938.09 and a period of performance through March 18, 2024. This delivery order was issued under an existing indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential value of...
This federal contract award is for the delivery of Capecitabine 500 mg tablets in quantities of 120s. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,555.60 and is a Firm Fixed Price Delivery Order that runs through May 13, 2024. The award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,156.14 firm fixed-price delivery order is for the supply of 4567409313 - Capecitabine 500 mg Tablet 120s, a prescription medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,622.08 Firm Fixed Price delivery order is for the supply of 4,564,327,425 units of the cancer medication Capecitabine 500 mg tablets. The award is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the company's primary vehicle for providing a broad range of...
This federal contract award, with ID SPE2DB20D3103|SPE2DB21FQ1A4, was made by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,176.90 firm fixed-price delivery order is for the supply of 4554615032 - Capecitabine 500 mg Tablets, 120 tablets per bottle. The award is not designated under a set-aside program. It is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that...
This federal contract award, with an ID of SPE2DB20D3103|SPE2DB21FQ0Q9, was granted by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,313.28 firm fixed-price delivery order is for the supply of 4554574464 - Capecitabine 150 mg tablets. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The $1,761.90 award is for the supply of 4563170212 - CAPECITABINE 500 MG TABLET 120S, a pharmaceutical product, with a completion date of December 26, 2023. No set-aside designations were used. Amerisourcebergen Drug Corp has previously received numerous DLA contract awards...
This federal contract award is for a Delivery Order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the provision of pharmaceutical products and medical supplies. The contract has a ceiling value of $7,053.19 and an ultimate completion date of February 6, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of the pharmaceutical product XCOPRI 100 mg tablets. The contract has a ceiling value of $1,624.02 and runs through February 14, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. The company holds a...